Literature DB >> 14707787

Magnetic resonance imaging of activated proliferating rhesus macaque T cells labeled with superparamagnetic monocrystalline iron oxide nanoparticles.

J Bruce Sundstrom1, Hui Mao, Robert Santoianni, Francois Villinger, Dawn M Little, Toai T Huynh, Ann E Mayne, Encai Hao, Aftab A Ansari.   

Abstract

Imaging of adoptively transferred cells in vivo by magnetic resonance imaging (MRI) could provide important information on disease-related patterns of lymphocyte homing in nonhuman primate models of AIDS. As a preliminary study to assess the feasibility of visualizing activated rhesus T cells by MRI, anti-CD3/CD28-expanded CD4+ T lymphocytes were labeled in vitro with monocrystalline iron oxide nanoparticles (MION). Intracellular incorporation of MION was determined by transmission electron microscopy (TEM) and inductively coupled plasma mass spectrography (ICP-MS). Pretreatment with colchicine did not affect MION labeling, suggesting that cellular uptake of MION occurred by adsorptive pinocytosis or receptor-mediated endocytosis. TEM analysis revealed that MION were intracellularly compartmentalized exclusively in the cytoplasm and did not cause any measurable physiologic effects on T-cell function, including viability, proliferation, synthesis of select cytokines (interleukin [IL]-2, IL-4, IL-6, IL-10, tumor necrosis factor-alpha, and interferon-gamma), activation antigens (CD25 and CD69), adhesion molecules (alpha4beta7 and CD49d), and susceptibility to in vitro infection with simian immunodeficiency virus mac239. A sensitivity of 0.05% (1 MION-labeled T cell in 2000 unlabeled cells) could be achieved using T2-weighted gradient echo imaging. Furthermore, under these experimental conditions, the MRI signal did not decrease in proliferating MION-labeled CD4+ T cells over a period of 120 hours. These results indicate that intracellular labeling with MION can be a useful technique for noninvasively monitoring trafficking patterns of adoptively transferred leukocyte subsets in real-time by MRI in nonhuman primate models of AIDS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14707787     DOI: 10.1097/00126334-200401010-00002

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  8 in total

1.  Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells.

Authors:  Daniel L J Thorek; Andrew Tsourkas
Journal:  Biomaterials       Date:  2008-06-03       Impact factor: 12.479

Review 2.  Immunological effects of iron oxide nanoparticles and iron-based complex drug formulations: Therapeutic benefits, toxicity, mechanistic insights, and translational considerations.

Authors:  Ankit Shah; Marina A Dobrovolskaia
Journal:  Nanomedicine       Date:  2018-02-02       Impact factor: 5.307

Review 3.  Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.

Authors:  Aaron Joseph L Villaraza; Ambika Bumb; Martin W Brechbiel
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 4.  Using cross-species comparisons and a neurobiological framework to understand early social deprivation effects on behavioral development.

Authors:  Zoë H Brett; Kathryn L Humphreys; Alison S Fleming; Gary W Kraemer; Stacy S Drury
Journal:  Dev Psychopathol       Date:  2015-05

Review 5.  Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect.

Authors:  Hari Krishna Sajja; Michael P East; Hui Mao; Y Andrew Wang; Shuming Nie; Lily Yang
Journal:  Curr Drug Discov Technol       Date:  2009-03

6.  Labeling of stem cells with monocrystalline iron oxide for tracking and localization by magnetic resonance imaging.

Authors:  Sergio Li Calzi; David L Kent; Kyung-Hee Chang; Kyle R Padgett; Aqeela Afzal; Saurav B Chandra; Sergio Caballero; Denis English; Wendy Garlington; Paul S Hiscott; Carl M Sheridan; Maria B Grant; John R Forder
Journal:  Microvasc Res       Date:  2009-04-05       Impact factor: 3.514

7.  Tracking and treating activated T cells.

Authors:  N H Kim; V Nadithe; M Elsayed; O M Merkel
Journal:  J Drug Deliv Sci Technol       Date:  2013-01-01       Impact factor: 3.981

8.  Antibody-conjugated paramagnetic nanobeads: kinetics of bead-cell binding.

Authors:  Shahid Waseem; Michael A Allen; Stefan Schreier; Rachanee Udomsangpetch; Sebastian C Bhakdi
Journal:  Int J Mol Sci       Date:  2014-05-19       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.